Wednesday, June 21, 2017 2:22:03 PM
think Stryker has been very complacent about emerging tech ,mainly due to its leading strength in the Ortho segment (this is not uncommon in various industries and the skeletons of similarly over confident companies are littered) --- and has failed to see how significant the dangers are of transformational tech. The bashers of the AMDA stock, don't kid yourself, has also affected the Stryker over confidence with their own tech.. "Asleep at the switch" comes to mind....
Lets assume that Stryker, for what ever reason, "wakes up", from its tech hibernation, and see that AMDA is cleaning the books, auditing assets etc, and other hallmarks of a potential sale. Lets further assume, they understand how AMDA tech would likely help Zimmer take many Billions of their revenue away over the next 5 to 10 years and add incremental new revenue, from new sources, to Zimmer..
If you look at Strykers history, it looks to me to have more experience than Zimmer at growing by acquisition ... Even if Stryker has some kind of relationship with Zimmer currently likely this would be superficial. Anyways, based on these assumptions, why would Stryker sit back and let this deal happen with no interference (i.e. competing bid) from it .... even if they know of the personal connections between AMDA and Zimmer. So for example lets says Stryker calculates an AMDA sale to Zimmer would take $5 Billion off the Present Value (roughly equal to market cap) of Stryker.. and lets say Zimmer trys to low ball a $100 million bid for AMDA... Under this scenario, no matter what relationships are, it would make no sense for Stryker to just sit back and let this deal happen with no response. Even if Stryker thinks Zimmer may potentially outbid them , its better for Stryker to have Zimmer pay up at least , if they do succeed.
Bottom line is Stryker needs to wake up to emerging tech and protect their future by trying to own the tech at AMDA....The bashing and manipulation of AMDA hides the true value, and danger if in the hand of a competitor, of the technology..time is of the essence...
Lets assume that Stryker, for what ever reason, "wakes up", from its tech hibernation, and see that AMDA is cleaning the books, auditing assets etc, and other hallmarks of a potential sale. Lets further assume, they understand how AMDA tech would likely help Zimmer take many Billions of their revenue away over the next 5 to 10 years and add incremental new revenue, from new sources, to Zimmer..
If you look at Strykers history, it looks to me to have more experience than Zimmer at growing by acquisition ... Even if Stryker has some kind of relationship with Zimmer currently likely this would be superficial. Anyways, based on these assumptions, why would Stryker sit back and let this deal happen with no interference (i.e. competing bid) from it .... even if they know of the personal connections between AMDA and Zimmer. So for example lets says Stryker calculates an AMDA sale to Zimmer would take $5 Billion off the Present Value (roughly equal to market cap) of Stryker.. and lets say Zimmer trys to low ball a $100 million bid for AMDA... Under this scenario, no matter what relationships are, it would make no sense for Stryker to just sit back and let this deal happen with no response. Even if Stryker thinks Zimmer may potentially outbid them , its better for Stryker to have Zimmer pay up at least , if they do succeed.
Bottom line is Stryker needs to wake up to emerging tech and protect their future by trying to own the tech at AMDA....The bashing and manipulation of AMDA hides the true value, and danger if in the hand of a competitor, of the technology..time is of the essence...
Recent SYK News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2026 08:59:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2026 09:22:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2026 08:48:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/27/2026 12:49:46 PM
- Stryker Launches Pangea Plating System and Completes First Case in Europe • Business Wire • 05/26/2026 06:10:00 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/22/2026 02:27:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:21:47 PM
- BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem • Business Wire • 05/19/2026 09:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 08:37:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 07:27:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 07:11:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 03:10:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:04:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:01:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:58:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:52:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:48:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:45:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:41:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:34:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:24:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 05:02:58 PM
- Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio • GlobeNewswire Inc. • 05/07/2026 08:05:00 PM
